Liver Transplant in India 2026: Living Donor Programme, Costs and Success Rates

Liver Transplant in India 2026: Living Donor Programme, Costs and Success Rates
The liver is the body's largest solid organ — a metabolic powerhouse that performs over 500 critical functions. When the liver fails, the consequences cascade rapidly: fluid accumulation, coagulation failure, encephalopathy, and eventually multi-organ failure. End-stage liver disease is fatal without transplantation.
For African patients facing liver failure, the options are stark. Liver transplantation is simply not available in most African countries. The continent has functional transplant programmes in South Africa and Egypt, but these serve their own domestic patients first and involve long waiting lists. India offers a different answer: a mature, high-volume living donor liver transplant (LDLT) programme that provides access to life-saving surgery on a planned timeline.
Why Living Donor Liver Transplant?
The liver has a unique biological property that makes living donor transplantation possible: it regenerates. A donor can give approximately 60-65% of their liver (the right lobe) to the recipient, and both donor and recipient livers will regenerate to near-full function within 6-8 weeks.
This regenerative capacity makes LDLT the dominant transplant model in countries with limited deceased donor programmes — including India, South Korea, and Japan. For international patients, it provides a crucial advantage: you do not wait on a deceased donor list. If you have an eligible donor, the transplant can be planned and executed on a definite timeline.
Conditions That Require Liver Transplant
Liver transplantation is indicated for:
End-stage liver disease (cirrhosis) from:
- Chronic Hepatitis B infection (highly prevalent in sub-Saharan Africa — up to 8% of the population is chronically infected)
- Chronic Hepatitis C infection
- Alcoholic liver disease
- Non-alcoholic fatty liver disease / NASH
- Autoimmune hepatitis
- Primary biliary cholangitis
- Wilson's disease
Acute liver failure:
- Drug-induced liver failure
- Viral hepatitis-induced acute failure
Liver cancer:
- Hepatocellular carcinoma (HCC) within Milan criteria: single tumour ≤5 cm or up to 3 tumours ≤3 cm each, with no vascular invasion or distant spread
The prevalence of Hepatitis B in sub-Saharan Africa makes liver transplantation a significant need across the continent. Many patients with childhood HBV infection progress to cirrhosis and liver failure in their 40s and 50s — often at a more productive stage of life.
India's Liver Transplant Leadership
India has emerged as one of Asia's leading liver transplant destinations. The programme's development has been driven by several world-class surgeons and institutions that have accumulated extraordinary volume:
Medanta – The Medicity (Gurgaon)
The liver transplant programme at Medanta, led by surgeons who trained at leading international centres, performs over 350 LDLT procedures annually. Their outcomes are among the best in Asia.
Apollo Hospitals (Delhi and Chennai)
Apollo has established liver transplant programmes at multiple centres. Their international patient experience includes significant African patient volume.
BLK-Max Super Speciality Hospital (Delhi)
One of Delhi's most active liver transplant centres, with competitive costs and strong outcomes data.
Fortis Memorial Research Institute (Gurgaon)
Strong hepatobiliary surgery and transplant programme with dedicated international patient services.
Gleneagles Global Hospital (Chennai)
Particularly strong in South India for liver transplant, with good connectivity from East African airports.
Costs for Liver Transplant in India
| Procedure | Estimated Cost (India) | USA/UK Comparison |
|---|---|---|
| Living donor liver transplant (LDLT) | $35,000–50,000 | $300,000–500,000 |
| LDLT with additional complications | $50,000–80,000 | $500,000+ |
| Pre-transplant evaluation (recipient + donor) | $3,000–5,000 | $20,000+ |
| 6-8 week post-transplant monitoring | Included in package | Additional $50,000+ |
| Annual immunosuppression medications | $2,000–4,000/year | $15,000–25,000/year |
The cost difference is transformative. A complete liver transplant — surgery, hospital stay, and initial follow-up — costs approximately 10% of what it would in the United States.
Who Can Be a Liver Donor?
Donor eligibility is assessed rigorously to protect the donor's health:
Required criteria:
- Blood group compatible with recipient (O is universal donor; ABO-incompatible LDLT is possible but more complex)
- Age 18-55 years
- BMI under 30 (ideally under 25)
- No significant medical conditions
- No liver disease or elevated liver enzymes
- No history of alcohol abuse
- Willing to donate without any financial inducement
Evaluation process:
Donors undergo:
- Blood group and cross-match testing
- CT volumetry (to calculate donor liver volume and the portion that can be safely donated)
- Full liver function panel
- Hepatitis B, C, and HIV screening
- Cardiac and pulmonary evaluation
- Psychiatric evaluation (independent, to confirm voluntary consent)
If the donor passes all evaluations, the case is submitted to the State Authorisation Committee with documentation of the family relationship.
The Transplant Process: Timeline
4-8 weeks before travel:
- Complete preliminary recipient evaluation reports sent to India
- Identify potential donor(s)
- Hospital confirms preliminary suitability and quotes cost
Arrival in India (Week 1-2):
- Comprehensive recipient and donor evaluation at transplant centre
- CT volumetry for donor
- Final authorisation documentation prepared
State Authorisation Committee (Week 2-3):
- SAC reviews donor-recipient documentation
- Typically takes 5-10 working days once complete file is submitted
- Approval granted or additional documentation requested
Surgery (Week 3-4):
- Recipient and donor operations performed simultaneously
- Recipient surgery: 10-14 hours
- Donor surgery (right hepatectomy): 6-8 hours
Hospital recovery (Week 4-7):
- Recipient: 14-21 days in hospital
- Donor: 7-10 days in hospital
Out-of-hospital recovery in India (Week 7-10):
- Twice-weekly monitoring appointments
- Immunosuppression dose adjustments
- Tacrolimus level monitoring
Return home (Week 10-12):
- With full discharge summary, immunosuppression protocol, and 3-month medication supply
Immunosuppression: The Lifelong Commitment
Liver transplant recipients must take immunosuppression medications lifelong to prevent rejection. Primary agents include:
- Tacrolimus (primary immunosuppressant): $100-200/month in India
- Mycophenolate mofetil: $50-100/month in India
- Prednisolone (typically tapered): $5-10/month
Indian generic immunosuppressants are significantly more affordable than branded equivalents in Africa or the West. Arodya can arrange a supply of medications to take home, and can connect you with Indian pharmacies for ongoing postal supply.
Starting the Process
Begin your liver transplant inquiry at /intake. Our clinical team will review your diagnosis, assess the urgency of your situation, and recommend the most appropriate transplant centre for your specific condition.
Given the complexity of liver transplantation and the State Authorisation Committee process, early engagement is important — ideally while you are still compensated, before acute decompensation requires emergency intervention.
Read our overview of India's transplant ecosystem and organ shortage solutions for broader context on how India's transplant system works for international patients.
For patients with end-stage liver disease from Hepatitis B — the most common cause in sub-Saharan Africa — India's liver transplant programme represents not just a treatment option, but a genuine path back to a full life.





